---
title: "JAFRON products have obtained EU MDR certification"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/231819353.md"
description: "JAFRON recently announced that its Future F20 blood purification device has obtained EU Medical Device Regulation (MDR) certification, allowing it to be sold in the EU and other countries that recognize CE certification. This device can be used in conjunction with products such as blood perfusion devices and plasma bilirubin adsorbers that have already received MDR certification. It is expected to promote the company's marketing and sales in the EU market, enhance global market competitiveness, and have a positive impact on future operations"
datetime: "2025-03-14T08:32:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/231819353.md)
  - [en](https://longbridge.com/en/news/231819353.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/231819353.md)
generator: "portal-rs"
---

# JAFRON products have obtained EU MDR certification

According to the Zhitong Finance APP, JAFRON (300529.SZ) announced that it recently received a notification from the EU announcement agency, stating that the company's product Future F20 blood purification device has obtained the EU MDR certification issued in accordance with the EU Medical Devices Regulation (EU) 2017/745 (hereinafter referred to as "MDR"), allowing it to be sold in EU countries and other countries that recognize EU CE certification.

The approved Future F20 blood purification device can be used in conjunction with the company's previously MDR-certified blood perfusion devices and plasma bilirubin adsorbers, among other blood purification consumables. The approval of the Future F20 blood purification device for MDR certification will positively promote the marketing and sales of the company's blood purification devices and consumables in EU countries and other countries that recognize EU MDR certification, which is beneficial for further enhancing the global market competitiveness of the company's products and will have a positive impact on the company's future operations

### Related Stocks

- [300529.CN](https://longbridge.com/en/quote/300529.CN.md)

## Related News & Research

- [10:42 ETLMNTRIX Positioned as a Major Player in 2026 IDC MarketScape for Worldwide MDR/MXDR for the Enterprise](https://longbridge.com/en/news/296931327.md)
- [18:14 ETCISOs Risk MDR Buyer's Remorse Without Clear Procurement Requirements, Says Info-Tech Research Group](https://longbridge.com/en/news/297237993.md)
- [Germany's Merz urges EU to keep long-term budget affordable](https://longbridge.com/en/news/297184642.md)
- [Flexcon Announces Global Relaunch of PharmCal® BioMark with ISEGA Certification](https://longbridge.com/en/news/296800649.md)
- [MedicalRite Announces COVID-19 & Flu Combo Test for Better Health](https://longbridge.com/en/news/297204162.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**